Minireview:: Neuroprotective effects of estrogen -: New insights into mechanisms of action

被引:203
作者
Wise, PM [1 ]
Dubal, DB [1 ]
Wilson, ME [1 ]
Rau, SW [1 ]
Böttner, M [1 ]
机构
[1] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40536 USA
关键词
D O I
10.1210/en.142.3.969
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An accumulating body of evidence dearly establishes that estradiol is a potent neuroprotective and neurotrophic factor in the adult: it influences memory and cognition, decreases the risk and delays the onset of neurological diseases such as Alzheimer's disease, and attenuates the extent of cell death that results from brain injuries such as cerebrovascular stroke and neurotrauma. Thus, estradiol appears to act at two levels: 1) it decreases the risk of disease or injury; and/or 2) it decreases the extent of injury incurred by suppressing the neurotoxic stimulus itself or increasing the resilience of the brain to a given injury. During the past century, the average life span of women has increased dramatically, whereas the time of the menopause has remained essentially constant. Thus, more women will live a larger fraction of their lives in a postmenopausal, hypoestrogenic state than ever before. Clearly, it is critical for us understand the circumstances under which estradiol exerts protective actions and the cellular and molecular mechanisms that underlie these novel, nonreproductive actions.
引用
收藏
页码:969 / 973
页数:5
相关论文
共 96 条
[51]   Expression of nerve growth factor and trkA after transient focal cerebral ischemia in rats [J].
Lee, TH ;
Kato, H ;
Chen, ST ;
Kogure, K ;
Itoyama, Y .
STROKE, 1998, 29 (08) :1687-1696
[52]   DIFFERENTIAL REGULATION OF MESSENGER-RNAS FOR NERVE GROWTH-FACTOR, BRAIN-DERIVED NEUROTROPHIC FACTOR, AND NEUROTROPHIN-3 IN THE ADULT-RAT BRAIN FOLLOWING CEREBRAL-ISCHEMIA AND HYPOGLYCEMIC COMA [J].
LINDVALL, O ;
ERNFORS, P ;
BENGZON, J ;
KOKAIA, Z ;
SMITH, ML ;
SIESJO, BK ;
PERSSON, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (02) :648-652
[53]   Gene expression induced by cerebral ischemia: An apoptotic perspective [J].
MacManus, JP ;
Linnik, MD .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1997, 17 (08) :815-832
[54]  
MANOLAGAS SC, 2000, P INT S BIOL MEN, P134
[55]   Estrogen to treat Alzheimer's disease: Too little, too late? So what's a woman to do? [J].
Marder, K ;
Sano, M .
NEUROLOGY, 2000, 54 (11) :2035-2037
[56]  
MATTHEWS KA, 2000, P INT S BIOL MEN, P147
[57]   ESTROGEN MODULATION OF MESSENGER-RNA LEVELS FOR THE 2 FORMS OF GLUTAMIC-ACID DECARBOXYLASE (GAD) IN FEMALE RAT-BRAIN [J].
MCCARTHY, MM ;
KAUFMAN, LC ;
BROOKS, PJ ;
PFAFF, DW ;
SCHWARTZGIBLIN, S .
JOURNAL OF COMPARATIVE NEUROLOGY, 1995, 360 (04) :685-697
[58]  
McMillan PJ, 1996, J NEUROSCI, V16, P1860
[59]   Tyrosine kinase/p21(ras)/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells [J].
Migliaccio, A ;
DiDomenico, M ;
Castoria, G ;
deFalco, A ;
Bontempo, P ;
Nola, E ;
Auricchio, F .
EMBO JOURNAL, 1996, 15 (06) :1292-1300
[60]   The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties [J].
Moosmann, B ;
Behl, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) :8867-8872